|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:CEO
|
gptkb:Richard_Pops
|
|
gptkbp:countryOfOperation
|
gptkb:Ireland
|
|
gptkbp:focusesOn
|
oncology
central nervous system diseases
|
|
gptkbp:foundedYear
|
1987
|
|
gptkbp:fullName
|
gptkb:Alkermes_plc
|
|
gptkbp:headquartersLocation
|
gptkb:Dublin,_Ireland
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
IE00B56GVS15
|
|
gptkbp:listedOn
|
gptkb:NASDAQ_Biotechnology_Index
gptkb:S&P_400
|
|
gptkbp:notableProduct
|
gptkb:Aristada
gptkb:Lybalvi
gptkb:Vivitrol
|
|
gptkbp:numberOfEmployees
|
~2300
|
|
gptkbp:researchFacilityLocation
|
gptkb:Athlone,_Ireland
gptkb:Waltham,_Massachusetts,_USA
|
|
gptkbp:stockSymbol
|
gptkb:ALKS
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
https://www.alkermes.com/
|
|
gptkbp:bfsParent
|
gptkb:Automated_Lane_Keeping_Systems
gptkb:NASDAQ:_ALKS
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
ALKS
|